Project Grant R43DA060641
Award Date
7/15/25
Completion Date
4/30/26
Dollars Obligated
$406K
Federal Agency
National Institute on Drug Abuse
Awardee
Ksana Health Inc. (KLNCNGPNB7Y8)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Eugene, OR, USA
Similar Awards
This federal Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop and evaluate the VIRA platform, a digital therapeutic intervention to improve outcomes for individuals with opioid use disorder (OUD) who are receiving buprenorphine treatment. The $611,665 award will fund a two-phase project to: 1) adapt and refine the VIRA platform through user-centered design and pilot testing,...
This Project Grant award, with a total funding amount of $958,629, was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The funding will support the real-world adoption of an innovative digital health therapeutic called KIOS, which uses nonlinear control theory to track multiple symptoms (e.g., craving, mood, pain) and deliver personalized, evidence-based intervention strategies to patients with opioid use disorder...
The National Institute on Drug Abuse (NIDA) awarded a $2,729,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Rhode Island. The purpose of this 2-year award, with a start date of September 15, 2024, is to rigorously develop and evaluate a mobile health intervention for adults with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential OUD treatment. The proposed mobile app...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $591,752 Project Grant to Oprems LLC to develop a digital platform for electronic screening to identify the risk of opioid misuse and overdose. The project aims to integrate the tools and processes from Oprems' existing paper-based "ONE (Opioid and Naloxone Education)" program into a tablet-based digital platform. This digital platform will be used to consistently...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and test a prototype mobile health (mHealth) application called R-ASSIST. The $857,121 award, with a project period from Sep 30, 2024 to Sep 29, 2025, will fund a partnership between the University of Massachusetts and Meaningful Measurement, Inc., a women-owned small business, to create an app to support individuals released from jail who...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $608,046 to Evidation Health, Inc. to develop a digital product called "Research and Engagement on Substance Use Harnessing Awareness and Personalized Education (RESHAPE)". The objective is to create a comprehensive digital experience to improve well-being and self-efficacy for individuals with substance use disorder (SUD) and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will pilot an innovative digital Contingency Management (CM) treatment delivered via mobile device to Medicaid beneficiaries with co-occurring opioid and alcohol use disorders. The $390,000 award, spanning from September 2024 to August 2027, aims to: 1) identify optimal approaches to engage Medicaid beneficiaries in digital CM through Medicaid claims data...
This Project Grant award of $591,032 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to Square2 Systems Inc. in Hanover, NH. The funding will support the development of the "COGITO" platform, a turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics for the prevention, treatment, and management of substance use disorders and other behavioral health conditions. The...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $280,207 to Mobile Health Interventions LLC to develop a digital intervention called the Adolescent CLEAR30 to reduce cannabis use among youth aged 13-17. The proposed intervention will include personalized feedback, daily communications, guided meditations, resource pages, multimedia content, optional human support, and an AI-driven...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $348,756 to the University of Oklahoma Health Sciences Center to develop a mobile health (mHealth) intervention that provides psychosocial and self-management support to postpartum individuals recovering from opioid use disorder (OUD). The intervention, grounded in acceptance and commitment therapy (ACT) principles, will be iteratively developed...